Home > Cashflow Statement > BIOCON

BIOCON
Cash Flow from Operating Activities

    Back to Cashflow Statement
BIOCON is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Top Undervalued Mid Cap Stocks
COMMUNITY POLL
for BIOCON
Please provide your vote to see the results

BIOCON Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Cash Flow from Operating Activities ₹1,994 Cr₹4,061 Cr₹2,954 Cr₹1,853 Cr₹1,177 Cr

What is the latest Cash Flow from Operating Activities ratio of BIOCON ?

The latest Cash Flow from Operating Activities ratio of BIOCON is ₹1,994 Cr based on Mar2026 Consolidated results.
Year Cash Flow from Operating Activities
Mar2026₹1,994 Cr
Mar2025₹4,061 Cr
Mar2024₹2,954 Cr
Mar2023₹1,853 Cr
Mar2022₹1,177 Cr

How is Cash Flow from Operating Activities of BIOCON Trending?

Years Cash Flow from Operating Activities % Change
Mar2026 ₹1,994 Cr
-50.90
Mar2025 ₹4,061 Cr
37.49
Mar2024 ₹2,954 Cr
59.45
Mar2023 ₹1,853 Cr
57.45
Mar2022 ₹1,177 Cr -

Compare Cash Flow from Operating Activities of peers of BIOCON

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BIOCON ₹59,769.2 Cr 6.8% 5.1% -3.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹459,497.0 Cr 8.1% 9.3% 9% Stock Analytics
DIVIS LABORATORIES ₹294,146.0 Cr 10.5% 18% 51.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹181,474.0 Cr 2.9% 2.1% 30.7% Stock Analytics
DR REDDYS LABORATORIES ₹114,349.0 Cr -0.1% 16% 14.6% Stock Analytics
CIPLA ₹113,989.0 Cr 1.4% 8.1% -6.8% Stock Analytics


BIOCON Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BIOCON

6.8%

5.1%

-3.2%

SENSEX

7%

11.5%

-3.5%


You may also like the below Video Courses